Lind Global Fund II LP 13D and 13G filings for Quoin Pharmaceuticals, Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 8:11 pm Sale |
2023-12-31 | 13G | Quoin Pharmaceuticals, Ltd. QNRX |
Lind Global Fund II LP | 3,125 6.000% |
-1,000 (-24.24%) |
Filing |
| 2023-03-03 4:18 pm Purchase |
2023-02-24 | 13G | Quoin Pharmaceuticals, Ltd. QNRX |
Lind Global Fund II LP | 4,125 9.900% |
4,125 (New Position) |
Filing |